查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1718044

再生医学人工智慧市场（按技术、功能、发展阶段、应用和最终用户产业）—2025 年至 2030 年全球预测

Artificial Intelligence in Regenerative Medicine Market by Technology, Functionality, Stage Of Development, Application, End-User Industry - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

再生医学人工智慧市场预计到 2024 年将达到 1.9046 亿美元，到 2025 年将达到 2.317 亿美元，复合年增长率为 22.16%，到 ​​2030 年将达到 6.3317 亿美元。

主要市场统计数据
基准年2024年 1.9046亿美元
预计年份：2025年 2.317亿美元
预测年份 2030 6.3317亿美元
复合年增长率（%） 22.16%

人工智慧正迅速成为再生医学领域的变革力量，为诊断、治疗和復健提供前所未有的能力。透过将复杂的演算法与临床专业知识相结合，专家们正在为组织工程、个人化治疗和患者照护策略开闢新的可能性。在当前的情况下，AI不再只是一个辅助工具；它是推动创新、改善病人治疗效果和加速救生治疗发展的核心要素。

资料科学与生物医学研究的交叉正在促使临床医生、科学家和工程师应对复杂医学挑战的方式发生转变。这种演变的特点是能够处理大量资料、识别有意义的模式并以以前无法达到的精度预测结果。无论是增强诊断影像技术或优化药物发现流程，人工智慧与再生医学的整合都代表着向更有效率、证据驱动的未来的动态转变。

本概述探讨了这项技术的诸多好处，讨论了整个行业正在发生的变革性变化，对关键细分市场进行了分类，并提供了针对区域和公司的见解。这里展开的故事凸显了人工智慧在克服再生医学传统限制方面的战略重要性，使其成为致力于开拓下一代医疗解决方案的相关人员的重要资产。

人工智慧将如何改变再生医学

近年来，人工智慧与再生医学的融合引发了一场变革，正在重塑产业格局。传统的再生医学方法常常受到漫长的研究週期和经验方法的阻碍，而人工智慧的预测和分析能力则大大增强了再生医学的方法。这一转变标誌着一些重要的进步。

其中最主要的是治疗计划决策的革命。演算法现在可以即时分析患者的特定数据，从而製定根据患者病情动态调整的个人化治疗计划。这种程度的客製化曾经是一个难以实现的目标，现在可以透过迭代机器学习过程和现实世界的资料整合来实现。

此外，人工智慧与关键生物医学影像处理技术的融合正在提高再生程序的精确度。改进的影像处理使临床医生能够准确评估组织损伤并在分子水平上监测癒合过程。这些能力支持在临床环境中采取更积极的方法，其中快速干预可能意味着康復和慢性之间的区别。

最后，人工智慧的应用也在不断扩大，以优化临床测试和监管调查。透过在严格的计算模型中模拟数百种场景，研究团队可以自信地简化临床测试，加快监管核准，并最终更快地将创新治疗方法推向市场。这不仅最大限度地提高了效率，而且还确保患者能够更快地受益于尖端治疗。

人工智慧再生医学市场分析及关键细分领域洞察

人工智慧再生医学市场的细分是多方面的，反映了多样化的技术创新和应用机会。在基于技术研究市场时，必须认识到电脑视觉、机器学习演算法、自然语言处理和机器人等领域都为整体格局贡献了各自独特的能力。例如，电脑视觉正在透过影像处理和视讯分析等专门的子领域发展，从而实现准确的视觉诊断和治疗结果的追踪。同时，机器学习演算法分为深度学习、强化学习、监督式学习和无监督学习，每种演算法在分析深度和自适应学习方面各有优势。自然语言处理透过语音辨识和文字分析的应用而增强，透过将非结构化临床数据转化为可操作的见解来补充这些技术。

在功能方面，市场对决策支援系统、预测分析和工作流程优化等主题进行了审查。这些功能突显了增强临床决策流程和简化医疗程序的业务优势。研究工作进一步延伸至开发阶段的评估，其中临床和临床前测试等环节发挥关键作用，并作为再生医学人工智慧应用成熟度和检验的重要基准。

而且应用领域复杂多元，涉及心血管疾病、神经内科、肿瘤科、眼科、骨科等广泛领域。每个治疗领域进一步细分，心血管应用分为心肌梗塞治疗和血管组织修復，神经学则专注于神经退化性疾病和创伤性脑损伤修復。同样，在肿瘤学领域，我们正在研究癌症疫苗和基因转移疗法的创新；在眼部科学领域，我们正在研究角膜修復以及视网膜疾病的治疗；在整形外科，我们正在深入研究骨再生、软骨修復和脊椎疾病的治疗。最后，我们将最终用户产业视为细分的重要观点。在这里，学术研究机构、生物技术公司和医院诊所提供了清晰的见解，反映了这一快速发展的领域中各个相关人员的不同需求和策略重点。

目录

第一章 引言

第二章调查方法

第三章执行摘要

第四章 市场概述

第五章 市场洞察

  • 市场动态
    • 驱动程式
      • 全球范围内慢性病的盛行率正在上升
      • 生技公司加大对人工智慧再生医学的投资
      • 人工智慧在再生医学自动化数据分析和预测建模中的作用日益扩大
    • 限制因素
      • 开发基于人工智慧的再生医学解决方案高成本
    • 机会
      • 人工智慧驱动的预测模型的出现，用于早期发现和个人化治疗退化性疾病
      • 利用机器学习优化干细胞疗法以改善患者治疗效果
    • 任务
      • 人工智慧在再生医学的应用资料隐私问题
  • 市场区隔分析
    • 技术：机器学习演算法在诊断和个人化医疗的广泛效用
    • 终端用户产业：生物技术公司在药物研发中越来越多地采用人工智慧
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 经济
    • 社会
    • 科技
    • 法律
    • 环境

第六章 再生医学人工智慧市场（按技术）

  • 介绍
  • 电脑视觉
    • 影像处理
    • 影片分析
  • 机器学习演算法
    • 深度学习
    • 强化学习
    • 监督学习
    • 无监督学习
  • 自然语言处理
    • 语音辨识
    • 文字分析
  • 机器人技术

第七章再生医学市场中的人工智慧（按功能）

  • 介绍
  • 决策支援系统
  • 预测分析
  • 优化您的工作流程

第八章再生医学人工智慧市场（依发展阶段）

  • 介绍
  • 临床
  • 临床前

第九章再生医学人工智慧市场（按应用）

  • 介绍
  • 心血管疾病
    • 心肌梗塞的治疗
    • 血管组织修復
  • 神经病学
    • 神经退化性疾病
    • 修復创伤性脑损伤
  • 肿瘤学
    • 癌症疫苗
    • 基因转移疗法
  • 眼科
    • 角膜修復
    • 视网膜疾病治疗
  • 整形外科
    • 骨再生
    • 软骨修復
    • 脊椎疾病的治疗

第 10 章。按最终用户行业分類的再生医学市场中的人工智慧

  • 介绍
  • 学术研究所
  • 生技公司
  • 医院和诊所

第 11 章美国再生医学人工智慧市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

12. 亚太再生医学人工智慧市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十三章欧洲、中东和非洲再生医学人工智慧市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十四章竞争格局

  • 2024年市场占有率分析
  • 2024年FPNV定位矩阵
  • 竞争情境分析
  • 战略分析与建议

公司名单

  • Aiforia Technologies Plc
  • Aspen Neuroscience
  • Celularity Inc.
  • Cognetivity Ltd.
  • Deep Genomics Incorporated
  • Exscientia plc
  • F. Hoffmann-La Roche Ltd.
  • Intel Corporation
  • Juvenescence Therapeutics Limited
  • Medtronic PLC
  • Merck KGaA
  • Microsoft Corporation
  • Novo Nordisk A/S
  • NVIDIA Corporation
  • Pandorum Technologies Pvt. Ltd
  • Recursion Pharmaceuticals
  • Sanofi SA
  • SOMITE THERAPEUTICS.
  • Tempus Labs, Inc.
  • Wipro Limited
Product Code: MRR-A6768A62EE02

The Artificial Intelligence in Regenerative Medicine Market was valued at USD 190.46 million in 2024 and is projected to grow to USD 231.70 million in 2025, with a CAGR of 22.16%, reaching USD 633.17 million by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 190.46 million
Estimated Year [2025] USD 231.70 million
Forecast Year [2030] USD 633.17 million
CAGR (%) 22.16%

Artificial Intelligence has rapidly emerged as a transformative force in the realm of regenerative medicine, offering unprecedented capabilities for diagnosis, treatment, and recovery. By integrating sophisticated algorithms with clinical expertise, professionals are unlocking new potential in tissue engineering, personalized therapies, and patient care strategies. In the current landscape, AI is not just an auxiliary tool but a core component driving innovation, improving patient outcomes, and accelerating the development of life-saving therapies.

The intersection of data science and biomedical research has spurred a shift in how clinicians, scientists, and technologists approach complex medical challenges. This evolution is characterized by the ability to process enormous amounts of data, discern meaningful patterns, and predict outcomes with a degree of precision that was previously unattainable. Whether through enhancing imaging techniques or optimizing drug discovery pipelines, AI's integration into regenerative medicine represents a dynamic shift towards a more efficient, evidence-based future.

In this summary, we explore the myriad benefits of this technology, discuss the transformative shifts taking shape across the industry, break down key market segments, and provide regional as well as company-specific insights. The narrative that unfolds highlights the strategic importance of AI in overcoming traditional limitations in regenerative care, making it an essential asset for stakeholders committed to pioneering next-generation medical solutions.

Transformative Shifts in Regenerative Medicine Driven by AI

In recent years, the integration of artificial intelligence in regenerative medicine has catalyzed transformative shifts that are reshaping the industry landscape. The traditional approach to regenerative therapies, often hindered by protracted research cycles and empirical methodologies, has been significantly augmented by the predictive and analytical prowess of AI. This shift is marked by several key advancements.

Foremost, decision-making in treatment planning has seen a revolution. Algorithms are now capable of analyzing patient-specific data in real time, thereby facilitating personalized treatment plans that adjust dynamically to the patient's progress. This level of customization was once an elusive goal but is now attainable through iterative machine learning processes and real-world data integration.

Moreover, the convergence of AI with critical biomedical imaging techniques has enhanced the precision of regenerative procedures. With improved image processing, clinicians can accurately assess tissue damage and monitor healing processes at a molecular level. These capabilities are driving a more proactive approach in clinical settings, where prompt interventions can make the difference between recovery and chronic conditions.

Finally, the use of AI extends into optimizing clinical trials and regulatory studies. By simulating hundreds of scenarios with rigorous computational models, research teams can confidently streamline trials, accelerate regulatory approvals, and ultimately bring innovative therapies to market more rapidly. The resulting improvements not only maximize efficiency but also ensure that patients benefit from state-of-the-art treatments sooner than ever.

Key Segmentation Insights: Dissecting the AI-Powered Regenerative Medicine Market

The segmentation of the market in AI-driven regenerative medicine is multifaceted, reflecting the diverse technological innovations and application opportunities. When examining the market based on technology, it is essential to recognize that areas such as Computer Vision, Machine Learning Algorithms, Natural Language Processing, and Robotics each contribute unique capabilities to the overall landscape. Computer Vision, for instance, evolves through specialized subdomains like Image Processing and Video Analysis, enabling precise visual diagnostics and tracking of therapeutic outcomes. In parallel, Machine Learning Algorithms are delineated into Deep Learning, Reinforcement Learning, Supervised Learning, and Unsupervised Learning, each offering distinct advantages in analytical depth and adaptive learning. Natural Language Processing, enriched by applications in Speech Recognition and Text Analysis, complements these technologies by transforming unstructured clinical data into actionable insights.

From a functionality perspective, the market is scrutinized under themes such as Decision Support Systems, Predictive Analysis, and Workflow Optimization. These functionalities underscore the operational benefits derived from enhancing clinical decision-making processes and streamlining medical procedures. Investigative efforts further extend to evaluating the Stage Of Development where segments such as Clinical Trials and Preclinical studies play pivotal roles, serving as critical benchmarks in the maturation and validation of AI applications in regenerative therapy.

Moreover, the application spectrum is complex and diverse, covering broad areas such as Cardiovascular Diseases, Neurology, Oncology, Ophthalmology, and Orthopedics. Each of these therapeutic domains is dissected further; cardiovascular applications branch into Myocardial Infarction Therapy and Vascular Tissue Repair, while neurology is characterized by its focus on Neurodegenerative Disorders and Traumatic Brain Injury Repair. Similarly, oncology examines innovations in Cancer Vaccine and Gene Transduction Therapy, ophthalmology explores Corneal Repair alongside Retinal Disease Therapy, and orthopedics delves into Bone Regeneration, Cartilage Repair, as well as Spinal Disorders Treatment. Finally, an essential perspective on segmentation considers the End-User Industry, where distinct insights emerge from Academic And Research Institutes, Biotechnology Companies, and Hospitals And Clinics, reflecting the varied needs and strategic priorities of different stakeholders in this fast-developing field.

Based on Technology, market is studied across Computer Vision, Machine Learning Algorithms, Natural Language Processing, and Robotics. The Computer Vision is further studied across Image Processing and Video Analysis. The Machine Learning Algorithms is further studied across Deep Learning, Reinforcement Learning, Supervised Learning, and Unsupervised Learning. The Natural Language Processing is further studied across Speech Recognition and Text Analysis.

Based on Functionality, market is studied across Decision Support Systems, Predictive Analysis, and Workflow Optimization.

Based on Stage Of Development, market is studied across Clinical Trials and Preclinical.

Based on Application, market is studied across Cardiovascular Diseases, Neurology, Oncology, Ophthalmology, and Orthopedics. The Cardiovascular Diseases is further studied across Myocardial Infarction Therapy and Vascular Tissue Repair. The Neurology is further studied across Neurodegenerative Disorders and Traumatic Brain Injury Repair. The Oncology is further studied across Cancer Vaccine and Gene Transduction Therapy. The Ophthalmology is further studied across Corneal Repair and Retinal Disease Therapy. The Orthopedics is further studied across Bone Regeneration, Cartilage Repair, and Spinal Disorders Treatment.

Based on End-User Industry, market is studied across Academic And Research Institutes, Biotechnology Companies, and Hospitals And Clinics.

Key Regional Insights: Embracing Global Diversity in AI Application

The advancement of AI in regenerative medicine finds varying degrees of adoption and innovation across different regions, each contributing uniquely to the global narrative. In the Americas, the emphasis is on leveraging advanced technological ecosystems, robust research infrastructures, and a strong investment climate to push the boundaries of clinical applications. This region has become a fertile ground for early-stage adoption and large-scale clinical deployments that set the pace for subsequent innovations.

Transitioning to Europe, the Middle East, and Africa, one observes strategic investments in integrated healthcare solutions that blend traditional practices with digital innovation. Here, regulatory frameworks encourage the adoption of AI-driven methodologies while balancing patient safety and technological advancement. The diverse socio-economic environments in this conglomerate area have fostered tailored approaches that are designed to meet local healthcare challenges and optimize regenerative therapies.

In the Asia-Pacific region, rapid economic growth and significant government-backed initiatives in research and development have led to an explosion of AI applications in regenerative medicine. The collaborative spirit between academic institutions, government agencies, and private sector innovators in this region is driving the creation of versatile solutions that address both emerging and established healthcare needs. This global perspective underscores the need for cross-regional collaboration and shared knowledge to harness AI's full potential in transforming regenerative medicine on a worldwide scale.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Key Companies Insights: Leaders Driving AI Innovation in Regenerative Therapies

The competitive landscape in AI-integrated regenerative medicine is defined by a host of innovative companies that are setting benchmarks in research, development, and clinical implementation. Industry pioneers such as Aiforia Technologies Plc and Aspen Neuroscience have been instrumental in pushing the envelope of AI-assisted diagnostic imaging and decision support. Celularity Inc. and Cognetivity Ltd. are noted for their contributions in refining machine learning techniques to enhance tissue regeneration processes and patient-specific therapeutic strategies.

Additionally, companies like Deep Genomics Incorporated have successfully leveraged artificial intelligence to decode complex genetic patterns, thereby informing regenerative therapies and preclinical research. Exscientia plc and F. Hoffmann-La Roche Ltd. continue to fortify the link between computational prowess and clinical excellence. The contributions of technology giants such as Intel Corporation, Microsoft Corporation, and NVIDIA Corporation have also facilitated the development of sophisticated computational models that streamline data analysis and accelerate breakthrough innovations.

The market also benefits from dynamic entities like Juvenescence Therapeutics Limited and Medtronic PLC, whose focus spans from enhanced surgical instruments to personalized medicine solutions. Merck KGaA and Novo Nordisk A/S, along with emerging innovators such as Pandorum Technologies Pvt. Ltd and Recursion Pharmaceuticals, exemplify the integration of advanced AI-driven tools in clinical test beds. Furthermore, global healthcare leaders such as Sanofi SA, SOMITE THERAPEUTICS, Tempus Labs, Inc., and Wipro Limited contribute significantly to refining the operational and clinical paradigms that underpin regenerative medicine, thereby ensuring robust, data-driven strategies are implemented at every stage of the therapeutic development process.

The report delves into recent significant developments in the Artificial Intelligence in Regenerative Medicine Market, highlighting leading vendors and their innovative profiles. These include Aiforia Technologies Plc, Aspen Neuroscience, Celularity Inc., Cognetivity Ltd., Deep Genomics Incorporated, Exscientia plc, F. Hoffmann-La Roche Ltd., Intel Corporation, Juvenescence Therapeutics Limited, Medtronic PLC, Merck KGaA, Microsoft Corporation, Novo Nordisk A/S, NVIDIA Corporation, Pandorum Technologies Pvt. Ltd, Recursion Pharmaceuticals, Sanofi SA, SOMITE THERAPEUTICS., Tempus Labs, Inc., and Wipro Limited. Actionable Recommendations for Industry Leaders in AI-Driven Regenerative Medicine

Industry leaders must embrace a proactive strategy to fully capitalize on the transformative potential of artificial intelligence in regenerative medicine. First, bolstering investments in innovative research and development is critical. Decision-makers are encouraged to allocate resources towards developing bespoke applications that align with the unique challenges of regenerative therapy, ensuring that AI algorithms are finely tuned to address specific biological complexities.

It is equally important to foster cross-disciplinary collaborations that bridge clinical expertise with technological innovation. Establishing partnerships between academic institutions, biotechnology companies, and clinical research centers can facilitate the creation of integrated solutions that combine cutting-edge AI techniques with advanced medical practices. This strategy not only enhances the accuracy of diagnostic protocols but also accelerates the timeline from research to clinical application.

Additionally, companies should prioritize the deployment of scalable and flexible AI platforms. By adopting technologies that are both robust and adaptable, organizations can quickly respond to evolving clinical trends and regulatory frameworks. Furthermore, investing in comprehensive data security and patient privacy measures will build a strong foundation of trust and compliance, crucial to the sustained adoption of AI in sensitive medical environments.

Leaders are also advised to conduct regular performance assessments of implemented AI solutions. This involves comprehensive data audits and outcome analyses to ensure that systems deliver measurable improvements in patient care and operational efficiency. Strategic utilization of predictive analytics can further enhance decision-making, enabling proactive adjustments based on real-time data.

Finally, a commitment to continuous learning and skills development across the workforce is essential. Training programs that enhance digital literacy and technical proficiency among clinical and administrative staff will ensure that the full spectrum of AI-enhanced regenerative therapies is effectively leveraged. With these actionable strategies, industry leaders can drive sustainable innovation while simultaneously enhancing patient outcomes and operational efficiency.

Conclusion: Harnessing AI to Redefine the Future of Regenerative Medicine

In conclusion, the proactive integration of artificial intelligence in regenerative medicine is poised to revolutionize current therapeutic paradigms. The comprehensive analysis presented in this executive summary underscores how technological advancements such as sophisticated machine learning models, enhanced imaging techniques, and intricate data analytics are collectively transforming patient care and medical research.

By embracing AI, stakeholders across the spectrum-from clinical practitioners to research scientists and technology innovators-are better positioned to address complex medical challenges, drive down costs, and significantly improve patient outcomes. The market's diverse segmentation spanning technology, functionality, development stages, and applications further highlights the versatility of AI and its capacity to meet multifaceted clinical needs.

Global regional insights and the strategic initiatives of leading companies paint a picture of an industry in rapid evolution, where collaboration and innovation are steering the future of regenerative medicine. The detailed insights provided here serve as a clarion call for further investment, strategic collaborations, and continual innovation. As AI technologies mature and become more closely intertwined with regenerative medicine practices, the ensuing benefits will undoubtedly extend well beyond improved patient outcomes, heralding a new era in personalized and precision medicine.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of chronic diseases across the globe
      • 5.1.1.2. Growing investments from biotech and technology companies for AI-driven regenerative medicine
      • 5.1.1.3. Expanding the role of AI in automating data analysis and predictive modeling in regenerative therapies
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with the development of AI-driven regenerative medicine solutions
    • 5.1.3. Opportunities
      • 5.1.3.1. Emergence of AI-driven predictive modeling for early detection and personalized treatment of degenerative diseases
      • 5.1.3.2. Leveraging machine learning for optimizing stem cell therapies and improving patient outcomes
    • 5.1.4. Challenges
      • 5.1.4.1. Concern associated with data privacy in the incorporation of artificial intelligence in regenerative medicine
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Technology: Extensive utility of machine learning algorithms in diagnostics and personalized medicine
    • 5.2.2. End-User Industry: Growing AI adoption by biotechnology companies for drug discovery
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Artificial Intelligence in Regenerative Medicine Market, by Technology

  • 6.1. Introduction
  • 6.2. Computer Vision
    • 6.2.1. Image Processing
    • 6.2.2. Video Analysis
  • 6.3. Machine Learning Algorithms
    • 6.3.1. Deep Learning
    • 6.3.2. Reinforcement Learning
    • 6.3.3. Supervised Learning
    • 6.3.4. Unsupervised Learning
  • 6.4. Natural Language Processing
    • 6.4.1. Speech Recognition
    • 6.4.2. Text Analysis
  • 6.5. Robotics

7. Artificial Intelligence in Regenerative Medicine Market, by Functionality

  • 7.1. Introduction
  • 7.2. Decision Support Systems
  • 7.3. Predictive Analysis
  • 7.4. Workflow Optimization

8. Artificial Intelligence in Regenerative Medicine Market, by Stage Of Development

  • 8.1. Introduction
  • 8.2. Clinical Trials
  • 8.3. Preclinical

9. Artificial Intelligence in Regenerative Medicine Market, by Application

  • 9.1. Introduction
  • 9.2. Cardiovascular Diseases
    • 9.2.1. Myocardial Infarction Therapy
    • 9.2.2. Vascular Tissue Repair
  • 9.3. Neurology
    • 9.3.1. Neurodegenerative Disorders
    • 9.3.2. Traumatic Brain Injury Repair
  • 9.4. Oncology
    • 9.4.1. Cancer Vaccine
    • 9.4.2. Gene Transduction Therapy
  • 9.5. Ophthalmology
    • 9.5.1. Corneal Repair
    • 9.5.2. Retinal Disease Therapy
  • 9.6. Orthopedics
    • 9.6.1. Bone Regeneration
    • 9.6.2. Cartilage Repair
    • 9.6.3. Spinal Disorders Treatment

10. Artificial Intelligence in Regenerative Medicine Market, by End-User Industry

  • 10.1. Introduction
  • 10.2. Academic And Research Institutes
  • 10.3. Biotechnology Companies
  • 10.4. Hospitals And Clinics

11. Americas Artificial Intelligence in Regenerative Medicine Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Artificial Intelligence in Regenerative Medicine Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Artificial Intelligence in Regenerative Medicine Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2024
  • 14.2. FPNV Positioning Matrix, 2024
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Cellino awarded USD 25 million in funding from ARPA-H to advance regenerative medicine
    • 14.3.2. Northeastern University study highlights AI's potential in advancing stem cell manufacturing
    • 14.3.3. Axolotl Biologix and Carmell Therapeutics enter merger deal
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Aiforia Technologies Plc
  • 2. Aspen Neuroscience
  • 3. Celularity Inc.
  • 4. Cognetivity Ltd.
  • 5. Deep Genomics Incorporated
  • 6. Exscientia plc
  • 7. F. Hoffmann-La Roche Ltd.
  • 8. Intel Corporation
  • 9. Juvenescence Therapeutics Limited
  • 10. Medtronic PLC
  • 11. Merck KGaA
  • 12. Microsoft Corporation
  • 13. Novo Nordisk A/S
  • 14. NVIDIA Corporation
  • 15. Pandorum Technologies Pvt. Ltd
  • 16. Recursion Pharmaceuticals
  • 17. Sanofi SA
  • 18. SOMITE THERAPEUTICS.
  • 19. Tempus Labs, Inc.
  • 20. Wipro Limited

LIST OF FIGURES

  • FIGURE 1. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET MULTI-CURRENCY
  • FIGURE 2. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET MULTI-LANGUAGE
  • FIGURE 3. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET RESEARCH PROCESS
  • FIGURE 4. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, 2024 VS 2030
  • FIGURE 5. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
  • FIGURE 9. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY FUNCTIONALITY, 2024 VS 2030 (%)
  • FIGURE 11. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY FUNCTIONALITY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY STAGE OF DEVELOPMENT, 2024 VS 2030 (%)
  • FIGURE 13. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY STAGE OF DEVELOPMENT, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 15. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER INDUSTRY, 2024 VS 2030 (%)
  • FIGURE 17. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER INDUSTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 18. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 19. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 20. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 21. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 23. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 25. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 26. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 27. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET DYNAMICS
  • TABLE 7. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COMPUTER VISION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY IMAGE PROCESSING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY VIDEO ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COMPUTER VISION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY MACHINE LEARNING ALGORITHMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY DEEP LEARNING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY REINFORCEMENT LEARNING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY SUPERVISED LEARNING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY UNSUPERVISED LEARNING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY MACHINE LEARNING ALGORITHMS, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY SPEECH RECOGNITION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TEXT ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY ROBOTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY DECISION SUPPORT SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY PREDICTIVE ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY WORKFLOW OPTIMIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY STAGE OF DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY CLINICAL TRIALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY PRECLINICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY MYOCARDIAL INFARCTION THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY VASCULAR TISSUE REPAIR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY NEURODEGENERATIVE DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TRAUMATIC BRAIN INJURY REPAIR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY CANCER VACCINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY GENE TRANSDUCTION THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY CORNEAL REPAIR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY RETINAL DISEASE THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 46. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OPHTHALMOLOGY, 2018-2030 (USD MILLION)
  • TABLE 47. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY ORTHOPEDICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 48. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY BONE REGENERATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 49. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY CARTILAGE REPAIR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 50. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY SPINAL DISORDERS TREATMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 51. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
  • TABLE 52. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 53. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 54. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 55. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 56. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 57. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COMPUTER VISION, 2018-2030 (USD MILLION)
  • TABLE 58. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY MACHINE LEARNING ALGORITHMS, 2018-2030 (USD MILLION)
  • TABLE 59. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, 2018-2030 (USD MILLION)
  • TABLE 60. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 61. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY STAGE OF DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 62. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2030 (USD MILLION)
  • TABLE 64. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
  • TABLE 65. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 66. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OPHTHALMOLOGY, 2018-2030 (USD MILLION)
  • TABLE 67. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
  • TABLE 68. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 69. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 70. ARGENTINA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 71. ARGENTINA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COMPUTER VISION, 2018-2030 (USD MILLION)
  • TABLE 72. ARGENTINA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY MACHINE LEARNING ALGORITHMS, 2018-2030 (USD MILLION)
  • TABLE 73. ARGENTINA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, 2018-2030 (USD MILLION)
  • TABLE 74. ARGENTINA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 75. ARGENTINA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY STAGE OF DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 76. ARGENTINA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. ARGENTINA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2030 (USD MILLION)
  • TABLE 78. ARGENTINA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
  • TABLE 79. ARGENTINA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 80. ARGENTINA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OPHTHALMOLOGY, 2018-2030 (USD MILLION)
  • TABLE 81. ARGENTINA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
  • TABLE 82. ARGENTINA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 83. BRAZIL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 84. BRAZIL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COMPUTER VISION, 2018-2030 (USD MILLION)
  • TABLE 85. BRAZIL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY MACHINE LEARNING ALGORITHMS, 2018-2030 (USD MILLION)
  • TABLE 86. BRAZIL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, 2018-2030 (USD MILLION)
  • TABLE 87. BRAZIL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 88. BRAZIL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY STAGE OF DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 89. BRAZIL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. BRAZIL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2030 (USD MILLION)
  • TABLE 91. BRAZIL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
  • TABLE 92. BRAZIL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 93. BRAZIL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OPHTHALMOLOGY, 2018-2030 (USD MILLION)
  • TABLE 94. BRAZIL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
  • TABLE 95. BRAZIL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 96. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 97. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COMPUTER VISION, 2018-2030 (USD MILLION)
  • TABLE 98. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY MACHINE LEARNING ALGORITHMS, 2018-2030 (USD MILLION)
  • TABLE 99. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, 2018-2030 (USD MILLION)
  • TABLE 100. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 101. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY STAGE OF DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 102. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2030 (USD MILLION)
  • TABLE 104. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
  • TABLE 105. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 106. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OPHTHALMOLOGY, 2018-2030 (USD MILLION)
  • TABLE 107. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
  • TABLE 108. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 109. MEXICO ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 110. MEXICO ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COMPUTER VISION, 2018-2030 (USD MILLION)
  • TABLE 111. MEXICO ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY MACHINE LEARNING ALGORITHMS, 2018-2030 (USD MILLION)
  • TABLE 112. MEXICO ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, 2018-2030 (USD MILLION)
  • TABLE 113. MEXICO ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 114. MEXICO ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY STAGE OF DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 115. MEXICO ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. MEXICO ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2030 (USD MILLION)
  • TABLE 117. MEXICO ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
  • TABLE 118. MEXICO ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 119. MEXICO ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OPHTHALMOLOGY, 2018-2030 (USD MILLION)
  • TABLE 120. MEXICO ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
  • TABLE 121. MEXICO ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 122. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 123. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COMPUTER VISION, 2018-2030 (USD MILLION)
  • TABLE 124. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY MACHINE LEARNING ALGORITHMS, 2018-2030 (USD MILLION)
  • TABLE 125. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, 2018-2030 (USD MILLION)
  • TABLE 126. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 127. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY STAGE OF DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 128. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2030 (USD MILLION)
  • TABLE 130. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
  • TABLE 131. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 132. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OPHTHALMOLOGY, 2018-2030 (USD MILLION)
  • TABLE 133. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
  • TABLE 134. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 135. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COMPUTER VISION, 2018-2030 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY MACHINE LEARNING ALGORITHMS, 2018-2030 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, 2018-2030 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY STAGE OF DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2030 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OPHTHALMOLOGY, 2018-2030 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 150. AUSTRALIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 151. AUSTRALIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COMPUTER VISION, 2018-2030 (USD MILLION)
  • TABLE 152. AUSTRALIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY MACHINE LEARNING ALGORITHMS, 2018-2030 (USD MILLION)
  • TABLE 153. AUSTRALIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, 2018-2030 (USD MILLION)
  • TABLE 154. AUSTRALIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 155. AUSTRALIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY STAGE OF DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 156. AUSTRALIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 157. AUSTRALIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2030 (USD MILLION)
  • TABLE 158. AUSTRALIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
  • TABLE 159. AUSTRALIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 160. AUSTRALIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OPHTHALMOLOGY, 2018-2030 (USD MILLION)
  • TABLE 161. AUSTRALIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
  • TABLE 162. AUSTRALIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 163. CHINA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 164. CHINA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COMPUTER VISION, 2018-2030 (USD MILLION)
  • TABLE 165. CHINA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY MACHINE LEARNING ALGORITHMS, 2018-2030 (USD MILLION)
  • TABLE 166. CHINA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, 2018-2030 (USD MILLION)
  • TABLE 167. CHINA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 168. CHINA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY STAGE OF DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 169. CHINA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 170. CHINA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2030 (USD MILLION)
  • TABLE 171. CHINA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
  • TABLE 172. CHINA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 173. CHINA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OPHTHALMOLOGY, 2018-2030 (USD MILLION)
  • TABLE 174. CHINA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
  • TABLE 175. CHINA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 176. INDIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 177. INDIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COMPUTER VISION, 2018-2030 (USD MILLION)
  • TABLE 178. INDIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY MACHINE LEARNING ALGORITHMS, 2018-2030 (USD MILLION)
  • TABLE 179. INDIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, 2018-2030 (USD MILLION)
  • TABLE 180. INDIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 181. INDIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY STAGE OF DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 182. INDIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 183. INDIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2030 (USD MILLION)
  • TABLE 184. INDIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
  • TABLE 185. INDIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 186. INDIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OPHTHALMOLOGY, 2018-2030 (USD MILLION)
  • TABLE 187. INDIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
  • TABLE 188. INDIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 189. INDONESIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 190. INDONESIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COMPUTER VISION, 2018-2030 (USD MILLION)
  • TABLE 191. INDONESIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY MACHINE LEARNING ALGORITHMS, 2018-2030 (USD MILLION)
  • TABLE 192. INDONESIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, 2018-2030 (USD MILLION)
  • TABLE 193. INDONESIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 194. INDONESIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY STAGE OF DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 195. INDONESIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 196. INDONESIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2030 (USD MILLION)
  • TABLE 197. INDONESIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
  • TABLE 198. INDONESIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 199. INDONESIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OPHTHALMOLOGY, 2018-2030 (USD MILLION)
  • TABLE 200. INDONESIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
  • TABLE 201. INDONESIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 202. JAPAN ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 203. JAPAN ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COMPUTER VISION, 2018-2030 (USD MILLION)
  • TABLE 204. JAPAN ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY MACHINE LEARNING ALGORITHMS, 2018-2030 (USD MILLION)
  • TABLE 205. JAPAN ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, 2018-2030 (USD MILLION)
  • TABLE 206. JAPAN ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 207. JAPAN ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY STAGE OF DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 208. JAPAN ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 209. JAPAN ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2030 (USD MILLION)
  • TABLE 210. JAPAN ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
  • TABLE 211. JAPAN ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 212. JAPAN ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OPHTHALMOLOGY, 2018-2030 (USD MILLION)
  • TABLE 213. JAPAN ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
  • TABLE 214. JAPAN ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 215. MALAYSIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 216. MALAYSIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COMPUTER VISION, 2018-2030 (USD MILLION)
  • TABLE 217. MALAYSIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY MACHINE LEARNING ALGORITHMS, 2018-2030 (USD MILLION)
  • TABLE 218. MALAYSIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, 2018-2030 (USD MILLION)
  • TABLE 219. MALAYSIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 220. MALAYSIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY STAGE OF DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 221. MALAYSIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 222. MALAYSIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2030 (USD MILLION)
  • TABLE 223. MALAYSIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
  • TABLE 224. MALAYSIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 225. MALAYSIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OPHTHALMOLOGY, 2018-2030 (USD MILLION)
  • TABLE 226. MALAYSIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
  • TABLE 227. MALAYSIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 228. PHILIPPINES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 229. PHILIPPINES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COMPUTER VISION, 2018-2030 (USD MILLION)
  • TABLE 230. PHILIPPINES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY MACHINE LEARNING ALGORITHMS, 2018-2030 (USD MILLION)
  • TABLE 231. PHILIPPINES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, 2018-2030 (USD MILLION)
  • TABLE 232. PHILIPPINES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 233. PHILIPPINES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY STAGE OF DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 234. PHILIPPINES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 235. PHILIPPINES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2030 (USD MILLION)
  • TABLE 236. PHILIPPINES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
  • TABLE 237. PHILIPPINES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 238. PHILIPPINES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OPHTHALMOLOGY, 2018-2030 (USD MILLION)
  • TABLE 239. PHILIPPINES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
  • TABLE 240. PHILIPPINES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 241. SINGAPORE ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 242. SINGAPORE ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COMPUTER VISION, 2018-2030 (USD MILLION)
  • TABLE 243. SINGAPORE ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY MACHINE LEARNING ALGORITHMS, 2018-2030 (USD MILLION)
  • TABLE 244. SINGAPORE ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, 2018-2030 (USD MILLION)
  • TABLE 245. SINGAPORE ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 246. SINGAPORE ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY STAGE OF DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 247. SINGAPORE ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 248. SINGAPORE ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2030 (USD MILLION)
  • TABLE 249. SINGAPORE ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
  • TABLE 250. SINGAPORE ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 251. SINGAPORE ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OPHTHALMOLOGY, 2018-2030 (USD MILLION)
  • TABLE 252. SINGAPORE ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
  • TABLE 253. SINGAPORE ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 254. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 255. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COMPUTER VISION, 2018-2030 (USD MILLION)
  • TABLE 256. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY MACHINE LEARNING ALGORITHMS, 2018-2030 (USD MILLION)
  • TABLE 257. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, 2018-2030 (USD MILLION)
  • TABLE 258. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MA